Comparing Efficacy and Safety of Various Monoclonal Antibodies in Myasthenia Gravis: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials (P9-9.008)

Hassan Waseem; Zain Ul Abideen; Minahil Iqbal; SANIYA ISHTIAQ; Justin Chih-Yao Chen; Jamir Pitton Rissardo; Ana Letícia Fornari Caprara; Vishnu Byroju; Brandon Lucke‐Wold; Adam Dmytriw

doi:10.1212/wnl.0000000000212994

June 9, 2026Neurology

Comparing Efficacy and Safety of Various Monoclonal Antibodies in Myasthenia Gravis: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials (P9-9.008)

View Full Paper

Ask AI

Bookmark

Share

Key Points

To compare the efficacy and safety of different doses of monoclonal antibodies for treating myasthenia gravis.
Conducted a network meta-analysis of randomized controlled trials.
Evaluated various doses of monoclonal antibodies.
Assessed safety and effectiveness outcomes.
Identified differences in efficacy and safety among monoclonal antibodies.
Findings provide insights on optimal dosing for treatment.
Outcomes support informed choices for therapy in myasthenia gravis.

Implication

Network meta-analysis compares the effectiveness and safety of monoclonal antibodies in myasthenia gravis, suggesting optimized treatment options.

Abstract

This network meta-analysis aims to compare the safety and effectiveness of various doses of monoclonal antibodies used in Myasthenia Gravis (MG) treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Waseem et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf393faef96ed7f05611e https://doi.org/10.1212/wnl.0000000000212994

View Full Paper

Ask AI

Bookmark

Share

Comparing Efficacy and Safety of Various Monoclonal Antibodies in Myasthenia Gravis: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials (P9-9.008)

Key Points

Implication

Abstract

Discussion

Cite This Study

Comparing Efficacy and Safety of Various Monoclonal Antibodies in Myasthenia Gravis: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials (P9-9.008)

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading